Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae

Infection and Immunity

Volumn 64, Issue 11, 1996, Pages 4850-4853

  Szalai, A J ^a   Briles, D E ^b   Volanakis, J E ^a,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; COBROTOXIN;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GENE EXPRESSION; LETHALITY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TRANSGENE;

EID: 0029911455     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.11.4850-4853.1996     Document Type: Article

References (23)

1. Agrawal, A., J. M. Kilpatrick, and J. E. Volanakis. 1993. Structure and function of human C-reactive protein, p. 79-92. In A. Mackiewicz, I. Kushner, and H. Baummann (ed.), Acute phase proteins: molecular biology, biochemistry, and clinical applications. CRC Press, Ann Arbor, Mich.
2. Ciliberto, G., R. Arcane, E. F. Wagner, and U. Rüther, 1987. Inducible and tissue-specific expression of human C-reactive protein in transgenic mice. EMBO J. 6:4017-1022.
3. Ganrot, P. O., and C. O. Kindmark. 1969. C-reactive protein - a phagocytosis promoting factor. Scand. J. Clin. Lab. Invest. 24:215-219.
4. Guyre, P. M., A. S. Campbell, W. D. Kniffin, and M. W. Fanger. 1990. Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type I IgG Fc receptors. J. Clin. Invest. 86:1892-1886.
5. Horowitz, J., J. E. Volanakis, and D. E. Briles. 1987. Blood clearance of Streptococcus pneumoniae by C-reactive protein. J. Immunol. 138:2598-2603.
6. Hosea, S. W., E. J. Brown, and M. M. Frank. 1980. The critical role of complement in experimental pneumococcal sepsis. J. Infect. Dis. 142:903-909.
7. Kaplan, M. H., and J. E. Volanakis. 1974. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J. Immunol. 112:2135-2147.
8. Kilpatrick, J. M., and J. E. Volanakis. 1985. Opsonic properties of C-reactive protein. Stimulation by phorbol myristate acetate enables human neutrophils to phagocytize C-reactive protein-coated cells. J. Immunol. 134:3364-3370.
9. Kindmark, C.-O. 1971. Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria. Clin. Exp. Immunol. 8:941-948.
10. Le, P. T., M. T. Muller, and R. F. Mortensen. 1982. Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine. J. Immunol. 129:665-672.
11. Marnell, L. L., C. Mold, M. A. Volzer, R. W. Burlingame, and T. W. du Clos. 1995. C-reactive protein binds to FcR1 in transfected COS cells. J. Immunol. 155:2185-2193.
12. Mold, C., S. Nakayama, T. J. Holzer, H. Gewurz, and T. W. Du Clos. 1981. C-reactive protein is protective against Streptococcus pneumoniae infections in mice. J. Exp. Med. 154:1703-1708.
13. Nakayama, S., H. Gewurz, T. Holzer, T. W. Du Clos, and C. Mold. 1983. The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection. Clin. Exp. Immunol. 54:319-326.
14. Nunomura, W., Y. Takakuwa, and T. Higashi. 1994. Changes in serum concentration and mRNA level of rat C-reactive protein. Biochim. Biophys. Acta 1227:74-78.
15. Richardson, M. D., C. A. Gray, and G. S. Shankland. 1991. Opsonic effect of C-reactive protein on phagocytosis and intracellular killing of virulent and attenuated strains of Candida albicans by human neutrophils. FEMS Microbiol. Immunol. 3:341-344.
16. Richardson, M. D., G. S. Shankland, and C. A. Gray. 1991. Opsonizing activity of C-reactive protein in phagocytosis of Aspergillus fumigatus conidia by human neutrophils. Mycoses 34:141-143.
17. Szalai, A. J., D. E. Briles, and J. E. Volanakis. 1995. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J. Immunol. 155:2557-2563.
18. Taktak, Y. S., and B. Stenning. 1992. Solid phase enzyme immunoassays for the quantification of serum amyloid P (SAP) and complement component 3 (C3) proteins in acute-phase mouse sera. Horm. Metab. Res. 24:371-374.
19. Tebo, J. M., and R. F. Mortensen. 1990. Characterization and isolation of a C-reactive protein receptor from the human monocyte cell line U-937. J. Immunol. 144:231-238.
20. Till, G. O., M. L. Morganroth, R. Kunkel, and P. A. Ward. 1987. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat. Am. J. Pathol. 129:44-53.
21. Van den Berg, C., P. C. Aerts, and H. Van Dijk. 1991. In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje. J. Immunol. Methods 134:287-294.
22. Winkelstein, J. A. 1981. The role of complement in the host's defense against Streptococcus pneumoniae. Rev. Infect. Dis. 3:289-298.
23. Yother, J., J. E. Volanakis, and D. E. Briles. 1982. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. J. Immunol. 128:2374-2376.